About

May 13-14, 2027    Rome, Italy
6th International Conference on

Gastroenterology and Hepatology

 

The 5th International Conference on Gastroenterology and Hepatology, scheduled for May 13–14, 2027, in Rome, Italy, is a premier international scientific event dedicated to advancing research, clinical practice, and innovation in digestive and liver health. The conference will bring together leading gastroenterologists, hepatologists, physicians, surgeons, researchers, academicians, healthcare professionals, industry experts, and students from around the world to discuss the latest breakthroughs and emerging trends in the field.

Under the theme, "Advancing Digestive and Liver Health Through Innovation, Research, and Clinical Excellence," the conference provides a dynamic platform for presenting cutting-edge research, sharing clinical experiences, and fostering interdisciplinary collaboration. The scientific program will feature keynote lectures, plenary sessions, oral and poster presentations, workshops, panel discussions, and networking opportunities that encourage the exchange of knowledge and the development of innovative solutions to improve patient care.

Why Attend?

Participating in the 5th International Conference on Gastroenterology and Hepatology provides an excellent opportunity to stay at the forefront of digestive and liver healthcare through scientific exchange, professional networking, and clinical innovation.

  1. Gain insights into the latest research, clinical advancements, and emerging technologies in gastroenterology and hepatology.
  2. Learn from internationally recognized experts, keynote speakers, and leading researchers.
  3. Explore innovations in gastrointestinal endoscopy, liver disease management, precision medicine, and AI-driven healthcare.
  4. Present your research findings through oral and poster presentations.
  5. Network with clinicians, researchers, academicians, healthcare professionals, and industry leaders from across the globe.
  6. Participate in interactive workshops, panel discussions, and scientific sessions.
  7. Discover evidence-based approaches for diagnosing and treating gastrointestinal and liver disorders.
  8. Build collaborations for future research, clinical trials, and multidisciplinary projects.
  9. Earn participation certificates and enhance your professional development.
  10. Experience Rome, Italy, while engaging in a world-class scientific conference.

Target Audience

The conference welcomes professionals and researchers from academia, healthcare, research organizations, and industry, including:

  1. Gastroenterologists
  2. Hepatologists
  3. Gastrointestinal Surgeons
  4. Hepatobiliary Surgeons
  5. Endoscopists
  6. Internal Medicine Physicians
  7. Oncologists
  8. Pathologists
  9. Radiologists
  10. Clinical Researchers
  11. Medical Scientists
  12. Healthcare Professionals
  13. Nutritionists and Dietitians
  14. Pharmacologists
  15. Clinical Trial Specialists
  16. Biotechnology and Pharmaceutical Industry Professionals
  17. Medical Device Manufacturers
  18. Academicians and Faculty Members
  19. Medical Students, Residents, and Fellows
  20. Public Health Professionals and Healthcare 

Scientific Sessions & Tracks

The 5th International Conference on Gastroenterology and Hepatology will feature comprehensive scientific sessions covering the latest advances in digestive and liver health, clinical practice, translational research, and emerging technologies.

Track 1: Gastrointestinal Disorders

This session focuses on the diagnosis, prevention, and management of common and complex gastrointestinal diseases. Discussions will include upper and lower GI disorders, evidence-based treatment strategies, and innovations in patient care.

Gastrointestinal Diseases | GI Infections | Peptic Ulcer Disease | GI Bleeding | Chronic GI Disorders | Clinical Gastroenterology

Track 2: Hepatology and Liver Diseases

This track highlights advances in liver disease research and clinical management, including viral hepatitis, fatty liver disease, cirrhosis, and liver failure.

Hepatitis | Fatty Liver Disease | Cirrhosis | Liver Fibrosis | Liver Failure | Hepatic Complications

Track 3: Gastrointestinal Endoscopy

This session covers diagnostic and therapeutic endoscopic procedures, emerging endoscopic technologies, and minimally invasive interventions.

Upper GI Endoscopy | Colonoscopy | ERCP | EUS | Therapeutic Endoscopy | Capsule Endoscopy

Track 4: Liver Transplantation

This track focuses on pre-transplant evaluation, donor selection, immunosuppression, post-transplant complications, and long-term outcomes.

Liver Transplantation | Donor Management | Immunosuppression | Transplant Complications | Organ Preservation

Track 5: Gastrointestinal Oncology

This session explores the prevention, early detection, molecular profiling, and treatment of gastrointestinal cancers.

Esophageal Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | GI Tumor Biology | Precision Oncology

Track 6: Inflammatory Bowel Disease (IBD)

This track addresses pathogenesis, biomarkers, biologic therapies, disease monitoring, and personalized approaches for Crohn’s disease and ulcerative colitis.

Crohn’s Disease | Ulcerative Colitis | Biologic Therapy | IBD Biomarkers | Mucosal Healing

Track 7: Pancreatic Diseases

This session focuses on inflammatory and neoplastic pancreatic disorders, advanced imaging, and therapeutic strategies.

Acute Pancreatitis | Chronic Pancreatitis | Pancreatic Cancer | Pancreatic Cysts | Endoscopic Pancreatic Therapy

Track 8: Esophageal Disorders

This track covers reflux disease, motility disorders, Barrett’s esophagus, and esophageal malignancies.

GERD | Barrett’s Esophagus | Achalasia | Esophageal Motility | Esophageal Cancer

Track 9: Colorectal Diseases

This session discusses colorectal neoplasia, inflammatory and functional colorectal disorders, and surgical innovations.

Colorectal Polyps | Diverticular Disease | Colorectal Screening | Hemorrhoids | Colorectal Surgery

Track 10: Microbiome and Gut Health

This track explores gut microbiota, host-microbe interactions, microbiome-based therapies, and their role in digestive and systemic diseases.

Gut Microbiota | Dysbiosis | Probiotics | Prebiotics | Fecal Microbiota Transplantation

Track 11: Digestive Nutrition and Clinical Dietetics

This session focuses on nutritional assessment and dietary interventions in gastrointestinal and liver disorders.

Clinical Nutrition | Malabsorption | Enteral Nutrition | Parenteral Nutrition | Obesity and Metabolic Disorders

Track 12: Pediatric Gastroenterology

This track highlights digestive and liver diseases in infants, children, and adolescents, including congenital and inflammatory disorders.

Pediatric GI Disorders | Pediatric Liver Disease | Celiac Disease | Pediatric IBD | Nutrition in Children

Track 13: Artificial Intelligence in Gastroenterology

This session examines AI-assisted diagnosis, image analysis, predictive modeling, and digital health applications.

AI Endoscopy | Machine Learning | Digital Pathology | Predictive Analytics | Clinical Decision Support

Track 14: Advanced Imaging and Diagnostics

This track covers state-of-the-art imaging modalities and molecular diagnostics for gastrointestinal and liver diseases.

CT Imaging | MRI | Elastography | Molecular Diagnostics | Biomarkers | Advanced Pathology

Track 15: Functional Gastrointestinal Disorders

This session addresses disorders of gut-brain interaction, including IBS and functional dyspepsia.

Irritable Bowel Syndrome | Functional Dyspepsia | Gut-Brain Axis | Motility Disorders | Neuro-gastroenterology

Track 16: Hepatobiliary and Biliary Diseases

This track focuses on gallbladder and biliary tract disorders, cholestatic liver disease, and interventional management.

Gallstones | Cholangitis | Biliary Strictures | Cholestatic Disease | Biliary Interventions

Track 17: Gastrointestinal Surgery and Minimally Invasive Procedures

This session explores laparoscopic, robotic, and endoscopic surgical techniques for digestive diseases.

Laparoscopic Surgery | Robotic Surgery | Bariatric Surgery | Minimally Invasive GI Surgery | Enhanced Recovery

Track 18: Precision Medicine and Translational Research

This track highlights genomics, biomarkers, targeted therapies, and translational approaches to personalized digestive and liver care.

Genomics | Biomarker Discovery | Targeted Therapy | Personalized Medicine | Translational Gastroenterology

Track 19: Emerging Therapeutics and Clinical Trials

This session covers novel pharmacologic agents, biologics, regenerative medicine, and ongoing clinical research.

Biologic Therapies | Novel Drug Development | Stem Cell Therapy | Clinical Trial Design | Regenerative Medicine

Track 20: Global Perspectives in Gastroenterology and Hepatology

This track examines international guidelines, public health strategies, healthcare delivery, and future challenges in digestive and liver health.

Global GI Health | Hepatitis Elimination | Screening Programs | Health Policy | Preventive Gastroenterology | International Collaboration

Benefits of Participation

The 5th International Conference on Gastroenterology and Hepatology offers exceptional opportunities for scientific learning, professional development, networking, and global collaboration. Participants will gain valuable insights into the latest research, clinical innovations, and technological advancements in digestive and liver healthcare.

Benefits for Speakers

  1. Present original research to an international audience of experts.
  2. Publication opportunities for accepted abstracts in conference proceedings.
  3. Receive an official Speaker Certificate and CPD/CME participation (where applicable).
  4. Gain worldwide recognition for your research and clinical contributions.
  5. Engage with leading gastroenterologists, hepatologists, and healthcare professionals.
  6. Receive constructive feedback from renowned researchers and clinicians.
  7. Establish international research collaborations and academic partnerships.
  8. Enhance your academic profile and professional career.
  9. Showcase innovative clinical practices and scientific discoveries.
  10. Access all keynote sessions, workshops, and networking events.

Benefits for Delegates

  1. Learn about the latest advances in gastroenterology and hepatology.
  2. Attend keynote lectures delivered by internationally recognized experts.
  3. Explore emerging technologies, AI applications, and innovative treatment approaches.
  4. Participate in interactive scientific sessions, workshops, and panel discussions.
  5. Expand professional knowledge through evidence-based clinical updates.
  6. Network with physicians, surgeons, researchers, academicians, and industry leaders.
  7. Discover new diagnostic tools, medical devices, and pharmaceutical innovations.
  8. Exchange ideas and build collaborations with professionals from around the world.
  9. Receive an official Certificate of Participation.
  10. Enhance continuing education and professional development.

Benefits for Poster Presenters

  1. Present research findings to an international scientific audience.
  2. Gain valuable feedback from experts and conference participants.
  3. Increase the visibility and impact of your research.
  4. Compete for Best Poster Presentation Awards.
  5. Build collaborations with researchers and clinicians.
  6. Publish accepted abstracts in conference proceedings.
  7. Receive an official Poster Presentation Certificate.
  8. Network with leading experts in digestive and liver healthcare.

Benefits for Students & Young Researchers

  1. Present research in a global scientific forum.
  2. Learn from world-renowned experts and keynote speakers.
  3. Gain mentorship and career guidance from senior professionals.
  4. Expand scientific knowledge and research skills.
  5. Develop networking opportunities with international researchers.
  6. Explore academic and career opportunities in gastroenterology and hepatology.
  7. Participate in Young Researcher Awards and recognition programs.
  8. Receive certificates that strengthen academic portfolios.

Benefits for Sponsors & Exhibitors

  1. Showcase products, medical devices, pharmaceuticals, and healthcare solutions.
  2. Increase global brand visibility among healthcare professionals.
  3. Connect directly with clinicians, researchers, hospital administrators, and decision-makers.
  4. Generate high-quality business leads and strategic partnerships.
  5. Launch new products and technologies to an international audience.
  6. Strengthen relationships with healthcare organizations and industry leaders.
  7. Promote your organization through conference branding and digital marketing.
  8. Enhance corporate reputation within the global gastroenterology and hepatology community.
  9. Access exclusive networking opportunities with key stakeholders.
  10. Maximize return on investment through targeted audience engagement.

Market Analysis Report

The global Gastroenterology and Hepatology market is projected to reach approximately USD 65–75 billion by 2027, growing at a CAGR of 6–8%. Market growth is driven by the rising prevalence of gastrointestinal disorders, liver diseases, colorectal cancer, inflammatory bowel disease (IBD), obesity, and metabolic liver disorders, along with increasing demand for advanced diagnostics and minimally invasive procedures. North America continues to lead the market due to strong healthcare infrastructure, while the Asia-Pacific region is expected to witness the fastest growth owing to expanding healthcare investments and increasing disease awareness. Emerging technologies such as artificial intelligence, precision medicine, advanced endoscopy, molecular diagnostics, and microbiome-based therapies are transforming digestive and liver healthcare, creating significant opportunities for research, innovation, and global collaboration.

  abstracts@longdom.com
  finance@longdom.com
  support@longdom.com
Speakers Interview